The commercialisation of insulin

As the nineteenth century drew to a close, newly developed vaccines and antitoxins were promising to alter the course of several devastating infectious diseases, such as diphtheria, tetanus and smallpox. Countries then had to confront the costs involved in adopting these therapies, and decide whethe...

Full description

Saved in:
Bibliographic Details
Published in:Anaesthesia and intensive care 2023-09, Vol.51 (5), p.312-315
Main Authors: Ball, Christine M, Featherstone, Peter J
Format: Article
Language:English
Subjects:
Antitoxins
Diabetes
Drug factories
Drug prices
History of medicine
Humans
Infection
Insulin
Pharmaceutical industry
Prevention
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As the nineteenth century drew to a close, newly developed vaccines and antitoxins were promising to alter the course of several devastating infectious diseases, such as diphtheria, tetanus and smallpox. Countries then had to confront the costs involved in adopting these therapies, and decide whether these would be borne by individuals or the state. This was the beginning of public health medicine as a specialty, a time of great change in the management of infectious diseases.
ISSN:0310-057X
1448-0271
DOI:10.1177/0310057X231179917